Una S. Ryan, Ph.D. to Address The MIT Enterprise Forum of Cambridge's Fall Workshop
Monday October 21, 11:01 am ET
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 21, 2002--The MIT Enterprise Forum of Cambridge, a nationally recognized resource for entrepreneurs and emerging businesses, today announced that Una S. Ryan, Ph.D., President and Chief Executive Officer of AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN - News) will present at the Forum's Fall Workshop on October 26, to be held from 7:00 a.m. to 1:45 p.m. at the Newton Marriott, 2345 Commonwealth Avenue, Newton, MA. Dr. Ryan will participate in the plenary session entitled, "Making Your Own Luck - The CEO Perspective," at 9:15 a.m, which will discuss how successful CEO's are managing in a tough economy.
"The MIT Enterprise Forum of Cambridge has long been the premier venue for industry thought leaders, influential companies and entrepreneurs to learn, connect, and grow together. This Fall's Workshop provides another outstanding opportunity to hear how the region's most successful enterprises and corporate managers are navigating through rough economic waters to achieve business success," said Forrest Milder, Chair, Executive Committee, MIT Enterprise Forum of Cambridge. Please visit mitforumcambridge.org for full agenda details and event pricing.
The MIT Enterprise Forum of Cambridge is renowned for the high level of collected business experts who share their knowledge with the entrepreneurial community at its Workshops and other events. While the Forum is affiliated with MIT, its events are open to all entrepreneurs, leaders of emerging businesses and business partners interested in developing successful strategies and programs to build their respective enterprises. In addition to the Workshops, the Forum has developed a variety of programs that educate, inform and support the entrepreneur, including monthly case presentations, coaching clinics, and seminars, while simultaneously offering excellent networking opportunities. Each event is designed to offer the entrepreneurial community assistance, support and feedback to help with enterprise development even at the earliest stages.
About AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a broad portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines aimed at protecting travelers from cholera, typhoid fever and other illnesses. In addition, the company is conducting clinical studies of a proprietary vaccine candidate for cholesterol management. AVANT further leverages the value of its technology portfolio through corporate partnerships. Current collaborations encompass the development of an oral human rotavirus vaccine, vaccines to combat threats of biological warfare, and vaccines addressed to human food safety and animal health.
Additional information on AVANT Immunotherapeutics, Inc. can be obtained through our site on the World Wide Web: avantimmune.com.
About the MIT Enterprise Forum of Cambridge
The MIT Enterprise Forum of Cambridge is a volunteer, non-profit organization whose mission is to promote and strengthen the process of starting and growing innovative and technology-oriented companies by providing services and programs that educate, inform, and support the entrepreneurial community. Over the past 25 years, it has assisted approximately 1,500 companies by making their business plans more attractive to financial resources, building management teams, focusing on specific markets, developing strategic alliances, and increasing profits. Each year, more than 4000 people attend more than 40 events sponsored by the MIT Enterprise Forum of Cambridge. For additional information, visit www.mitforumcambridge.org or call (617) 253-8240.
--------------------------------------------------------------------------------
Contact:
HighGround, Inc.
Joe Romano, 781/246-5522 ext. 208
jromano@highgroundinc.com
or
MIT Enterprise Forum of Cambridge
Katja Wald, 617/253-2568
kwald@mit.edu
or
AVANT Immunotherapeutics, Inc.
Una S. Ryan, Ph.D., 781/433-0771
info@avantimmune.com
--------------------------------------------------------------------------------
Source: AVANT Immunotherapeutics, Inc. |
